Common variants in the TPH1 and TPH2 regions are not associated with persistent ADHD in a combined sample of 1,636 adult cases and 1,923 controls from four European populations

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 5, 2010, Pages 1008-1015

  Johansson, Stefan ^a,b   Halmøy, Anne ^a   Mavroconstanti, Thegna ^a   Jacobsen, Kaya K ^a,b   Landaas, Elisabeth T ^a,b   Reif, Andreas ^c   Jacob, Christian ^c   Boreatti Hümmer, Andrea ^c   Kreiker, Susanne ^c   Lesch, Klaus Peter ^c   Kan, Cornelis C ^d   Kooij, J J Sandra ^e   Kiemeney, Lambertus A ^f   Buitelaar, Jan K ^d   Franke, Barbara ^d,f   Ribasés, Marta ^g   Bosch, Rosa ^g   Bayés, Mònica ^h,i,j   Casas, Miguel ^g,k   Ramos Quiroga, Josep Antoni ^g,k   Cormand, Bru ^l,m   Knappskog, Per ^a,b   Haavik, Jan ^a,b   more..

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d RADBOUD UNIVERSITY   (Netherlands)

^e Parnassia   (Netherlands)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^h CENTRE FOR GENOMIC REGULATION CRG   (Spain)

ⁱ CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^j Centro Nacional de Genotipado CeGen   (Spain)

^k UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^l UNIVERSITY OF BARCELONA   (Spain)

^m CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

more..

Author keywords

ADHD; Common variants; Genetic analysis; TPH1; TPH2

Indexed keywords

TRYPTOPHAN HYDROXYLASE; TRYPTOPHAN HYDROXYLASE 1; TRYPTOPHAN HYDROXYLASE 2; UNCLASSIFIED DRUG; GENETIC MARKER; TPH1 PROTEIN, HUMAN; TPH2 PROTEIN, HUMAN;

ADULT; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; EUROPEAN AMERICAN; EXON; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; GERMANY; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NORWAY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; ALLELE; CASE CONTROL STUDY; CAUCASIAN; DEMOGRAPHY; ENZYMOLOGY; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS (TOPIC);

ADULT; ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; DEMOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXONS; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; META-ANALYSIS AS TOPIC; NORWAY; POLYMORPHISM, SINGLE NUCLEOTIDE; TRYPTOPHAN HYDROXYLASE;

EID: 77954357411     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31067     Document Type: Article

References (34)

1. Allen NC, Bagade S, McQueen MB, Ioannidis JPA, Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L. 2008. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia. Nat Genet 40(7):827-834.
2. Altshuler D, Daly MJ, Lander ES. 2008. Genetic mapping in human disease. Science 322:881-888.
3. Baehne CG, Ehlis AC, Plichta MM, Conzelmann A, Pauli P, Jacob C, Gutknecht L, Lesch KP, Fallgatter AJ. 2008. Tph2 gene variants modulate response control processes in adult ADHD patients and healthy individuals. Mol Psychiatry 14(11):1032-1039.
4. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
5. Biederman J, Faraone SV. 2005. Attention-deficit hyperactivity disorder. Lancet 366:237-248.
6. Brookes K, Xu X, Chen W, Zhou K, Neale B, Lowe N, Anney R., et al. 2006. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: Association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry 11:934-953.
7. Cote F, Fligny C, Bayard E, Launay JM, Gershon MD, Mallet J, Vodjdani G. 2007. Maternal serotonin is crucial for murine embryonic development. Proc Natl Acad Sci USA 104:329-334.
8. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. 2005. Efficiency and power in genetic association studies. Nat Genet 37:1217-1223.
9. Faraone SV, Biederman J, Mick E. 2006. The age-dependent decline of attention deficit hyperactivity disorder: A meta-analysis of follow-up studies. Psychol Med 36:159-165.
10. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D. 2002. The structure of haplotype blocks in the human genome. Science 296: 2225-2229.
11. Goldstein DB. 2009. Common genetic variation and human traits. N Engl J Med 360:1696-1698.
12. Gutknecht L, Kriegebaum C, Waider J, Schmitt A, Lesch KP. 2009. Spatiotemporal expression of tryptophan hydroxylase isoforms in murine and human brain: Convergent data from Tph2 knockout mice. Eur Neuropsychopharmacol 19:266-282.
13. Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, Howes MJ, Jin R, Secnik K, Spencer T, Ustun TB, Walters EE. 2005. The World Health Organization Adult ADHD Self-Report Scale (ASRS): A short screening scale for use in the general population. Psychol Med 35:245-256.
14. Kuntsi J, Neale BM, Chen W, Faraone SV, Asherson P. 2006. The IMAGE project: Methodological issues for the molecular genetic analysis of ADHD. Behav Brain Funct 2:27.
15. Larsson JO, Larsson H, Lichtenstein P. 2004. Genetic and environmental contributions to stability and change of ADHDsymptoms between 8 and 13 years of age: A longitudinal twin study. J Am Acad Child Adolesc Psychiatry 43:1267-1275.
16. Li J, Wang YF, Zhou RL, Yang L, Zhang HB, Wang B. 2003. Association between tryptophan hydroxylase gene polymorphisms and attention deficit hyperactivity disorder with or without learning disorder. Zhonghua Yi Xue Za Zhi 83:2114-2118.
17. Li J, Wang Y, Zhou R, Zhang H, Yang L, Wang B, Faraone SV. 2006. Association between tryptophan hydroxylase gene polymorphisms and attention deficit hyperactivity disorder in Chinese Han population. Am J Med Genet B Neuropsychiatr Genet 141B:126-129.
18. Manor I, Laiba E, Eisenberg J, Meidad S, Lerer E, Israel S, Gritsenko I, Tyano S, Faraone SV, Ebstein RP. 2008. Association between tryptophan hydroxylase 2, performance on a continuance performance test and response to methylphenidate in ADHD participants. Am J Med Genet B Neuropsychiatr Genet 147B:1501-1508.
19. McKinney J, Knappskog PM, Haavik J. 2005. Different properties of the central and peripheral forms of human tryptophan hydroxylase. J Neurochem 92:311-320. (Pubitemid 40194022)
20. McKinney J, Johansson S, Halmoy A, Dramsdahl M, Winge I, Knappskog PM, Haavik J. 2008. A loss-of-function mutation in tryptophan hydroxylase 2 segregating with attention-deficit/hyperactivity disorder. Mol Psychiatry 13:365-367.
21. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR, Hinds DA, Pennacchio LA, Tybjaerg-Hansen A, Folsom AR, Boerwinkle E, Hobbs HH, Cohen JC. 2007. A common allele on chromosome 9 associated with coronary heart disease. Science 316:1488-1491. (Pubitemid 46906617)
22. Need AC, Ge D, Weale ME, Maia J, Feng S, Heinzen EL, Shianna KV., et al. 2009. A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet 5:e1000373.
23. Oades RD. 2007. Role of the serotonin system in ADHD: Treatment implications. Expert Rev Neurothe 7:1357-1374.
24. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. 2007. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575.
25. Ribases M, Ramos-Quiroga JA, Hervas A, Bosch R, Bielsa A, Gastaminza X, Artigas J, Rodriguez-Ben S, Estivill X, Casas M, Cormand B, Bayes M. 2009. Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB. Mol Psychiatry 14: 71-85.
26. Sanchez-Mora CRM, Ramos-Quiroga JA, Casas M, Bosch R, Boreatti-Hummer A, Heine M, Jacob CP, Lesch K-P, Fasmer OB, Knappskog PM, Sandra Kooij JJ, Kan C, Buitelaar JK, Mick E, Asherson P, Faraone SV, Franke B, Johansson S, Haavik J, Reif A, Bayes M, Cormand B. 2009. Meta-analysis of brain-derived neurotrophic factor p. Val66met in adult ADHD in four European populations. Am J Med Genet Part B DOI: 10.1002/ajmg.b.31008.
27. Savelieva KV, Zhao S, Pogorelov VM, Rajan I, Yang Q, Cullinan E, Lanthorn TH. 2008. Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants. PLoS ONE 3:e3301.
28. Sheehan K, Lowe N, Kirley A, Mullins C, Fitzgerald M, Gill M, Hawi Z. 2005. Tryptophan hydroxylase 2 (TPH2) gene variants associated with ADHD. Mol Psychiatry 10:944-949.
29. Sheehan K, Hawi Z, Gill M, Kent L. 2007. No association between TPH2 gene polymorphisms and ADHD in a UK sample. Neurosci Lett 412: 105-107.
30. Walitza S, Renner TJ, Dempfle A, Konrad K, Wewetzer C, Halbach A, Herpertz-Dahlmann B, Remschmidt H, Smidt J, Linder M, Flierl L, Knolker U, Friedel S, Schafer H, Gross C, Hebebrand J, Warnke A, Lesch KP. 2005. Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder. Mol Psychiatry 10:1126-1132.
31. Walther DJ, Peter JU, Bashammakh S, Hortnagl H, Voits M, Fink H, Bader M. 2003. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299:76.
32. Ward MF, Wender PH, Reimherr FW. 1993. The Wender Utah Rating Scale: An aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 150:885-890.
33. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, Hu T, de Bakker PI., et al. 2008. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40:638-645. (Pubitemid 351601209)
34. Zill P, Buttner A, Eisenmenger W, Muller J, Moller HJ, Bondy B. 2009. Predominant expression of tryptophan hydroxylase 1 mRNA in the pituitary: A postmortem study in human brain. Neuroscience 159: 1274-1282.